OVERALL SURVIVAL AND TRANSPLANTATION IN PATIENTS WITH FLT3 MUTATIONS: SUBGROUP ANALYSIS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED, HIGH-RISK ACUTE MYELOID LEUKEMIA
Publication
, Conference
Medeiros, BC; Hogge, D; Newell, LF; Bixby, DL; Solomon, SR; Strickland, SA; Lin, TL; Erba, H; Powell, BL; Podoltsev, N; Ryan, R; Chiarella, M ...
Published in: HAEMATOLOGICA
June 26, 2017
Duke Scholars
Published In
HAEMATOLOGICA
ISSN
0390-6078
Publication Date
June 26, 2017
Volume
102
Start / End Page
53 / 54
Location
Madrid, SPAIN
Publisher
FERRATA STORTI FOUNDATION
Conference Name
22nd Congress of the European-Hematology-Association
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Medeiros, B. C., Hogge, D., Newell, L. F., Bixby, D. L., Solomon, S. R., Strickland, S. A., … Lancet, J. E. (2017). OVERALL SURVIVAL AND TRANSPLANTATION IN PATIENTS WITH FLT3 MUTATIONS: SUBGROUP ANALYSIS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED, HIGH-RISK ACUTE MYELOID LEUKEMIA. In HAEMATOLOGICA (Vol. 102, pp. 53–54). Madrid, SPAIN: FERRATA STORTI FOUNDATION.
Medeiros, B. C., D. Hogge, L. F. Newell, D. L. Bixby, S. R. Solomon, S. A. Strickland, T. L. Lin, et al. “OVERALL SURVIVAL AND TRANSPLANTATION IN PATIENTS WITH FLT3 MUTATIONS: SUBGROUP ANALYSIS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED, HIGH-RISK ACUTE MYELOID LEUKEMIA.” In HAEMATOLOGICA, 102:53–54. FERRATA STORTI FOUNDATION, 2017.
Medeiros BC, Hogge D, Newell LF, Bixby DL, Solomon SR, Strickland SA, et al. OVERALL SURVIVAL AND TRANSPLANTATION IN PATIENTS WITH FLT3 MUTATIONS: SUBGROUP ANALYSIS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED, HIGH-RISK ACUTE MYELOID LEUKEMIA. In: HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2017. p. 53–4.
Medeiros, B. C., et al. “OVERALL SURVIVAL AND TRANSPLANTATION IN PATIENTS WITH FLT3 MUTATIONS: SUBGROUP ANALYSIS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED, HIGH-RISK ACUTE MYELOID LEUKEMIA.” HAEMATOLOGICA, vol. 102, FERRATA STORTI FOUNDATION, 2017, pp. 53–54.
Medeiros BC, Hogge D, Newell LF, Bixby DL, Solomon SR, Strickland SA, Lin TL, Erba H, Powell BL, Podoltsev N, Ryan R, Chiarella M, Louie AC, Lancet JE. OVERALL SURVIVAL AND TRANSPLANTATION IN PATIENTS WITH FLT3 MUTATIONS: SUBGROUP ANALYSIS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED, HIGH-RISK ACUTE MYELOID LEUKEMIA. HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2017. p. 53–54.
Published In
HAEMATOLOGICA
ISSN
0390-6078
Publication Date
June 26, 2017
Volume
102
Start / End Page
53 / 54
Location
Madrid, SPAIN
Publisher
FERRATA STORTI FOUNDATION
Conference Name
22nd Congress of the European-Hematology-Association
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology